A trail blazed through DNA vaccine, noninvasive vaccine, and innate-adaptive immunity duo

References

• Tang DC, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992; 356:152 - 4; http://dx.doi.org/10.1038/356152a0; PMID: 1545867
   PubMed Web of Science ®Google Scholar
• Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259:1745 - 9; http://dx.doi.org/10.1126/science.8456302; PMID: 8456302
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang C, Zhang L, Li J, Huang Z, Lu S. The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods. Vaccine 2008; 26:2100 - 10; http://dx.doi.org/10.1016/j.vaccine.2008.02.033; PMID: 18378365
   PubMed Web of Science ®Google Scholar
• Keane-Myers AM, Bell M. Evolution of electroporated DNA vaccines. Methods Mol Biol 2014; 1121:269 - 78; http://dx.doi.org/10.1007/978-1-4614-9632-8_24; PMID: 24510831
   PubMedGoogle Scholar
• Davtyan H, Ghochikyan A, Movsesyan N, Ellefsen B, Petrushina I, Cribbs DH, Hannaman D, Evans CF, Agadjanyan MG. Delivery of a DNA vaccine for Alzheimer’s disease by electroporation versus gene gun generates potent and similar immune responses. Neurodegener Dis 2012; 10:261 - 4; http://dx.doi.org/10.1159/000333359; PMID: 22301697
   PubMed Web of Science ®Google Scholar
• Kopycinski J, Cheeseman H, Ashraf A, Gill D, Hayes P, Hannaman D, Gilmour J, Cox JH, Vasan S. A DNA-based candidate HIV vaccine delivered via in vivo electroporation induces CD4 responses toward the α4β7-binding V2 loop of HIV gp120 in healthy volunteers. Clin Vaccine Immunol 2012; 19:1557 - 9; http://dx.doi.org/10.1128/CVI.00327-12; PMID: 22837097
   PubMed Web of Science ®Google Scholar
• Kim YC, Jarrahian C, Zehrung D, Mitragotri S, Prausnitz MR. Delivery systems for intradermal vaccination. Curr Top Microbiol Immunol 2012; 351:77 - 112; http://dx.doi.org/10.1007/82_2011_123; PMID: 21472533
   PubMed Web of Science ®Google Scholar
• Johnston SA, Tang DC. The use of microparticle injection to introduce genes into animal cells in vitro and in vivo. Genet Eng (N Y) 1993; 15:225 - 36; PMID: 7763843
   PubMedGoogle Scholar
• Norbury CC, Basta S, Donohue KB, Tscharke DC, Princiotta MF, Berglund P, Gibbs J, Bennink JR, Yewdell JW. CD8+ T cell cross-priming via transfer of proteasome substrates. Science 2004; 304:1318 - 21; http://dx.doi.org/10.1126/science.1096378; PMID: 15166379
   PubMed Web of Science ®Google Scholar
• Tang DC, Johnston SA, Carbone DP. Butyrate-inducible and tumor-restricted gene expression by adenovirus vectors. Cancer Gene Ther 1994; 1:15 - 20; PMID: 7621233
   PubMed Web of Science ®Google Scholar
• Goletz TJ, Klimpel KR, Leppla SH, Keith JM, Berzofsky JA. Delivery of antigens to the MHC class I pathway using bacterial toxins. Hum Immunol 1997; 54:129 - 36; http://dx.doi.org/10.1016/S0198-8859(97)00081-5; PMID: 9297531
   PubMed Web of Science ®Google Scholar
• Kutzler MA, Weiner DB. DNA vaccines: ready for prime time?. Nat Rev Genet 2008; 9:776 - 88; http://dx.doi.org/10.1038/nrg2432; PMID: 18781156
   PubMed Web of Science ®Google Scholar
• Eisenbraun MD, Fuller DH, Haynes JR. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol 1993; 12:791 - 7; http://dx.doi.org/10.1089/dna.1993.12.791; PMID: 8216850
   PubMed Web of Science ®Google Scholar
• Tang DC, Nguyen HH. The Yin-Yang arms of vaccines: disease-fighting power versus tissue-destructive inflammation. Expert Rev Vaccines 2014; 13:417 - 27; http://dx.doi.org/10.1586/14760584.2014.882775; PMID: 24502690
   PubMed Web of Science ®Google Scholar
• Tang DC, Shi Z, Curiel DT. Vaccination onto bare skin. Nature 1997; 388:729 - 30; http://dx.doi.org/10.1038/41917; PMID: 9285583
   PubMed Web of Science ®Google Scholar
• Glenn GM, Rao M, Matyas GR, Alving CR. Skin immunization made possible by cholera toxin. Nature 1998; 391:851; http://dx.doi.org/10.1038/36014; PMID: 9495336
   PubMed Web of Science ®Google Scholar
• Zhang J, Shi Z, Kong FK, Jex E, Huang Z, Watt JM, Van Kampen KR, Tang DC. Topical application of Escherichia coli-vectored vaccine as a simple method for eliciting protective immunity. Infect Immun 2006; 74:3607 - 17; http://dx.doi.org/10.1128/IAI.01836-05; PMID: 16714593
   PubMed Web of Science ®Google Scholar
• Pennisi E. Microbiology. Bacteria are picky about their homes on human skin. Science 2008; 320:1001; http://dx.doi.org/10.1126/science.320.5879.1001; PMID: 18497269
   PubMed Web of Science ®Google Scholar
• Glenn GM, Taylor DN, Li X, Frankel S, Montemarano A, Alving CR. Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat Med 2000; 6:1403 - 6; http://dx.doi.org/10.1038/82225; PMID: 11100128
   PubMed Web of Science ®Google Scholar
• Van Kampen KR, Shi Z, Gao P, Zhang J, Foster KW, Chen DT, Marks D, Elmets CA, Tang DC. Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine 2005; 23:1029 - 36; http://dx.doi.org/10.1016/j.vaccine.2004.07.043; PMID: 15620476
   PubMed Web of Science ®Google Scholar
• Weniger BG, Glenn GM. Cutaneous vaccination: antigen delivery into or onto the skin. Vaccine 2013; 31:3389 - 91; http://dx.doi.org/10.1016/j.vaccine.2013.05.048; PMID: 23684830
   PubMed Web of Science ®Google Scholar
• Zhang J, Tarbet EB, Toro H, Tang DC. Adenovirus-vectored drug-vaccine duo as a potential driver for conferring mass protection against infectious diseases. Expert Rev Vaccines 2011; 10:1539 - 52; http://dx.doi.org/10.1586/erv.11.141; PMID: 22043954
   PubMed Web of Science ®Google Scholar
• Croyle MA, Patel A, Tran KN, Gray M, Zhang Y, Strong JE, Feldmann H, Kobinger GP. Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice. PLoS One 2008; 3:e3548; http://dx.doi.org/10.1371/journal.pone.0003548; PMID: 18958172
   PubMed Web of Science ®Google Scholar
• Shi Z, Zeng M, Yang G, Siegel F, Cain LJ, van Kampen KR, Elmets CA, Tang DC. Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines. J Virol 2001; 75:11474 - 82; http://dx.doi.org/10.1128/JVI.75.23.11474-11482.2001; PMID: 11689629
   PubMed Web of Science ®Google Scholar
• Song K, Bolton DL, Wei CJ, Wilson RL, Camp JV, Bao S, Mattapallil JJ, Herzenberg LA, Herzenberg LA, Andrews CA, et al. Genetic immunization in the lung induces potent local and systemic immune responses. Proc Natl Acad Sci U S A 2010; 107:22213 - 8; http://dx.doi.org/10.1073/pnas.1015536108; PMID: 21135247
   PubMed Web of Science ®Google Scholar
• Zhang J, Jex E, Feng T, Sivko GS, Baillie LW, Goldman S, Van Kampen KR, Tang DC. An adenovirus-vectored nasal vaccine confers rapid and sustained protection against anthrax in a single-dose regimen. Clin Vaccine Immunol 2013; 20:1 - 8; http://dx.doi.org/10.1128/CVI.00280-12; PMID: 23100479
   PubMed Web of Science ®Google Scholar
• Tang DC. Comment letter on News & Analysis report “More woes for struggling HIV vaccine field”. Science Online 2013; (http://comments.sciencemag.org/content/10.1126/science.340.6133.667)
   Google Scholar
• Zhang J, Tarbet EB, Feng T, Shi Z, Van Kampen KR, Tang DC. Adenovirus-vectored drug-vaccine duo as a rapid-response tool for conferring seamless protection against influenza. PLoS One 2011; 6:e22605; http://dx.doi.org/10.1371/journal.pone.0022605; PMID: 21818346
   PubMed Web of Science ®Google Scholar